Skip to main content
Premium Trial:

Request an Annual Quote

Color Genomics Raises $45M in Series B Financing; Offers Patient Families Discounted Testing

NEW YORK (GenomeWeb) – Color Genomics has raised $45 million in a Series B financing round, bringing its total funding to date to $60 million, the company said today.

Separately, Color Genomics announced the Color Family Testing Program to offer genetic testing to parents, siblings, and adult children of patients with hereditary cancer mutations for $50 instead of $249. The program is supported by donations from the BRCA Foundation and private donors.

The financing round was led by General Catalyst, with participation from the singer Bono and from existing investors, including Susan L. Wagner, 8VC, Khosla Ventures, and Emerson Collective.

In connection with the investment, Susan Wagner, co-founder and COO of BlackRock, and Hemant Taneja, managing director at General Catalyst, have joined Color's board of directors.

Color Genomics, which is based in Burlingame, California, plans to use the proceeds to further expand its services. "The new funding will go toward bringing even more people access to potentially life-saving genetic information and building the open databases necessary to further global research and development around major diseases," Color Genomics co-founder and CEO Elad Gil said in a statement.

Launched in 2015, Color Genomics offers genetic testing for hereditary cancer in more than 150 countries. Its $249 Color Test analyzes 30 genes associated with inherited breast, colorectal, melanoma, ovarian, pancreatic, prostate, stomach, and uterine cancer.

The test is being used as part of the Women Informed to Screen Depending on Measures of Risk (WISDOM) study, led by the University of California, San Francisco, which plans to enroll 100,000 women.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.